ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag cancer biotech pharma clinical trials

How Vesselon Can Improve the Entire Class of Antibody-Drug Conjugates
Clayton Larsen - President & CEO, Vesselon, Inc. | Oct 30, 2023 | 4 min read
Vesselon’s novel co-formulation of gas lipid microspheres and self-assembling liposomes, targeted and activated by commercial ultrasound, would be an ideal adjunct to any of these ADC drugs.
Biotech Buys Autoimmune Firm for $7B
Kerry Grens | Jul 16, 2015 | 1 min read
Celgene has purchased Receptos, developer of an experimental multiple sclerosis drug.
2022 Top 10 Innovations 
2022 Top 10 Innovations
The Scientist | Dec 12, 2022 | 10+ min read
This year’s crop of winning products features many with a clinical focus and others that represent significant advances in sequencing, single-cell analysis, and more.
Cannabis Biotech
Daniel Cossins | Dec 1, 2014 | 8 min read
As medical marijuana businesses set up shop across the U.S., a handful of companies are taking the pharmaceutical route, guiding cannabis-derived drugs through clinical trials.
The Growth of Iowa Biotech
Jenny Rood | Aug 1, 2016 | 7 min read
The state’s industry draws inspiration from medicine as well as agriculture.
Lazarus Drugs
Kate Yandell | Feb 1, 2015 | 8 min read
While some drugs sail through development, others suffer setbacks, including FDA rejections, before reaching the market.
 
Biotech-Big Pharma Betrothals Declining
Sam Jaffe | Jul 7, 2002 | 5 min read
You've just started your job with a small biotech startup that has some promising drug candidates and a freewheeling culture. You enjoy the shorts and T-shirt dress code and the midnight pizza parties for late workers, as well as the generous stock options. But then it's announced that your company has sold a large equity stake to a mega-pharmaceutical company. Now you're expected to wear a suit when meeting with your partners. To make matters worse, the large equity stake the pharma company
The Vaginal Microbiome is Finally Getting Recognized
Hannah Thomasy, PhD, Drug Discovery News | Sep 25, 2023 | 10+ min read
Vaginal dysbiosis has long been a taboo subject, but studying and optimizing the vaginal microbiome could be a game changer for women's health.
Hearing Help
Kate Yandell | Sep 1, 2015 | 10+ min read
For decades, the only remedies for hearing loss were devices such as hearing aids or cochlear implants. Now, the first pharmaceutical treatments may be on the way.
 
The Companies that Failed
Edyta Zielinska | Dec 20, 2011 | 3 min read
A roundup of eight biotech companies that didn’t make it through this year's continuing tough economic times

Run a Search

ADVERTISEMENT